Skip to Main Content

Align Technology, Inc. (NASDAQ: ALGN) Securities Fraud Investigation

On July 30, 2025, after the market closed, Align Technology released its second quarter 2025 financial results. Specifically, Align Technology reported revenue of $1.012 billion, missing both its own guidance and analyst expectations. Additionally, Align Technology announced a significant reduction in third quarter 2025 revenue guidance, cut its full-year clear aligner volume growth expectations to “low-single digits,” and disclosed plans to incur $150–$170 million in restructuring and write-down charges in the second half of 2025.

On this news, Align Technology’s stock price fell nearly 37%, from a close of $203.57 on July 30, 2025, to close at $129.01 per share on July 31, 2025. 
 

If you have any questions or would like to discuss this investigation, please contact Kessler Topaz Meltzer & Check, LLP:  Jonathan Naji, Esq. (484) 270-1453 or via e-mail at info@ktmc.com.  

Complete this form with your transactions in Align Technology, Inc. securities between February 6, 2025 and July 30, 2025.

Click Here to Print PDF of this Form

SUBMIT YOUR INFORMATION
* Denotes required field
Date
# of Shares
Price per Share
Date
Principal Amount
Amount Paid
Series or CUSIP
Date
# of Contracts
Price per Contract
Exercise Price
Expiration Date
Did you purchase shares of Align Technology, Inc. prior to the Class Period?
Are you a current or former employee of Align Technology, Inc.?
The submission of this form does not create an attorney-client relationship, nor an obligation on the part of Kessler Topaz or you to file a lead plaintiff motion in this matter. Any information you submit will be maintained as confidential. If Kessler Topaz, in its sole discretion, believes that you might be an appropriate lead plaintiff candidate, Kessler Topaz will contact you to discuss the matter and whether to establish an attorney client relationship. By signing this form you are authorizing us to contact you regarding this case and/or future cases.
I agree to the KTMC disclaimer
I would like to receive new case alerts by email